These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 38266541

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H, Türkmen I, Başsüllü N, Dirican A, Karadağ N, Kirimlioğlu V.
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [Abstract] [Full Text] [Related]

  • 3. The epidemiological trends of biliary tract cancers in the United States of America.
    Jiang Y, Jiang L, Li F, Li Q, Yuan S, Huang S, Fu Y, Yan X, Chen J, Li H, Li S, Liu J.
    BMC Gastroenterol; 2022 Dec 29; 22(1):546. PubMed ID: 36581813
    [Abstract] [Full Text] [Related]

  • 4. Time to move to targeted drugs in biliary tract cancer?
    Louvet C, Tournigand C.
    Onkologie; 2010 Dec 29; 33(1-2):10-1. PubMed ID: 20164655
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma.
    Wheless M, Agarwal R, Goff L, Lockney N, Padmanabhan C, Heumann T.
    Curr Treat Options Oncol; 2024 Jan 29; 25(1):127-160. PubMed ID: 38177560
    [Abstract] [Full Text] [Related]

  • 7. Trends in Receipt of Adjuvant Chemotherapy and its Impact on Survival in Resected Biliary Tract Cancers.
    Rhodin KE, Liu A, Bartholomew A, Kramer R, Parameswaran A, Uronis H, Strickler J, Hsu D, Morse MA, Shah KN, Herbert G, Zani S, Nussbaum DP, Allen PJ, Lidsky ME.
    Ann Surg Oncol; 2023 Aug 29; 30(8):4813-4821. PubMed ID: 37188803
    [Abstract] [Full Text] [Related]

  • 8. Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: Demographics, pathology and survival.
    Koea J, Phillips A, Lawes C, Rodgers M, Windsor J, McCall J.
    ANZ J Surg; 2002 Dec 29; 72(12):857-61. PubMed ID: 12485219
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Establishment and characterisation of six human biliary tract cancer cell lines.
    Ku JL, Yoon KA, Kim IJ, Kim WH, Jang JY, Suh KS, Kim SW, Park YH, Hwang JH, Yoon YB, Park JG.
    Br J Cancer; 2002 Jul 15; 87(2):187-93. PubMed ID: 12107841
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Current diagnostics and therapy for carcinomas of the biliary tree and gallbladder].
    Wiedmann M, Schoppmeyer K, Witzigmann H, Hauss J, Mössner J, Caca K.
    Z Gastroenterol; 2005 Mar 15; 43(3):305-15. PubMed ID: 15765304
    [Abstract] [Full Text] [Related]

  • 19. Targeted therapies in advanced biliary tract cancers-a narrative review.
    LaPelusa M, Heumann T, Goff L, Agarwal R.
    Chin Clin Oncol; 2023 Apr 15; 12(2):14. PubMed ID: 36946186
    [Abstract] [Full Text] [Related]

  • 20. Integrating cytotoxic, targeted and immune therapies for cholangiocarcinoma.
    Merters J, Lamarca A.
    J Hepatol; 2023 Mar 15; 78(3):652-657. PubMed ID: 36400328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.